{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:08:24Z","timestamp":1792642104495,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/Objective<\/jats:title>\n                <jats:p>The effects of Chikungunya virus (CHIKV) infection on patients with rheumatic diseases have not been extensively studied. Our aim was to compare the clinical course of patients with rheumatoid arthritis and spondyloarthritis, categorized according to the use or not of biologic disease modifying anti-rheumatic drugs (bDMARDs), during and after infection by CHIKV.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients from a northeastern\u00a0Brazilian city that suffered an epidemic outbreak of Chikungunya fever (CHIK) between Oct 2015 and Jul 2016, on regular follow-up in a longitudinal registry of rheumatic patients (BiobadaBrasil), were invited to participate. Participants underwent a standardized clinical interview and collection of blood sample for serological tests (IgM\/IgG) for CHIKV. A positive IgG was considered evidence of previous CHIKV infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>105 patients (84 with rheumatoid arthritis, 17 with ankylosing spondylitis, and 4 with psoriatic arthritis) were evaluated. Most patients (58, 55.2%) were on therapy with bDMARDs. The overall prevalence of seropositivity for CHIKV was 47.6% (39.7% in patients on bDMARDs and 57.4% in those exclusively on conventional synthetic (cs-) DMARDs (<jats:italic>p<\/jats:italic>\u2009=\u20090.070). Among seropositive patients, asymptomatic disease had similar frequency in those treated and not treated with bDMARDs (39.1% versus 33.3%, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.670). However, patients exclusively on csDMARDs presented significantly higher prevalence of articular symptoms beyond 3\u00a0months and switched treatment more often than patients on bDMARDs (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 for both comparisons).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among rheumatic patients with CHIK, those on bDMARDs had shorter persistence of articular symptoms and switched treatment scheme less often than patients exclusively treated with csDMARDs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-022-00273-0","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:02:58Z","timestamp":1668438178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever"],"prefix":"10.1186","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-2288","authenticated-orcid":false,"given":"Aline","family":"Ranzolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Diniz Lopes","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurindo Ferreira","family":"da Rocha Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Luzia Branco Pinto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Deleon","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lays Miranda","family":"de Almeida Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson Rodrigues","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Stela Santana","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacyr Jesus Barreto","family":"de Melo R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Galdino","family":"da Rocha Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bredemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieda Maria Magalh\u00e3es","family":"Laurindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"4","key":"273_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101502","volume":"34","author":"CD Lopes Marques","year":"2020","unstructured":"Lopes Marques CD, Ranzolin A, Cavalcanti NG, et al. Arboviruses related with chronic musculoskeletal symptoms. Best Pract Res Clin Rheumatol. 2020;34(4): 101502.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"13","key":"273_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMra1406035","volume":"372","author":"SC Weaver","year":"2015","unstructured":"Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"273_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40122-021-00235-2","volume":"10","author":"SN El-Tallawy","year":"2021","unstructured":"El-Tallawy SN, Nalamasu R, Salem GI, et al. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021;10(1):181\u2013209.","journal-title":"Pain Ther"},{"issue":"3","key":"273_CR4","first-page":"494","volume":"36","author":"M Runowska","year":"2018","unstructured":"Runowska M, Majewski D, Niklas K, et al. Chikungunya virus: a rheumatologist\u2019s perspective. Clin Exp Rheumatol. 2018;36(3):494\u2013501.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"273_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/trstmh\/try063","volume":"112","author":"ES Paix\u00e3o","year":"2018","unstructured":"Paix\u00e3o ES, Rodrigues LC, Costa MCN, et al. Chikungunya chronic disease: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2018;112(7):301\u201316.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"273_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000389","volume":"3","author":"D Sissoko","year":"2009","unstructured":"Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3(3): e389.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"273_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002137","volume":"7","author":"C Schilte","year":"2013","unstructured":"Schilte C, Staikowsky F, Staikovsky F, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3): e2137.","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 2","key":"273_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.cmi.2018.01.029","volume":"24","author":"M Fern\u00e1ndez-Ruiz","year":"2018","unstructured":"Fern\u00e1ndez-Ruiz M, Meije Y, Manuel O, et al. ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction). Clin Microbiol Infect. 2018;24(Suppl 2):S2\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"273_CR9","doi-asserted-by":"publisher","first-page":"2071325","DOI":"10.1155\/2020\/2071325","volume":"2020","author":"CAA de Brito","year":"2020","unstructured":"de Brito CAA, Marques CDL, Fran\u00e7a RFO, et al. Reduced duration of postchikungunya musculoskeletal pain in rheumatological patients treated with biologicals. J Trop Med. 2020;2020:2071325.","journal-title":"J Trop Med"},{"issue":"7","key":"273_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s10067-015-2979-x","volume":"34","author":"V Rosario","year":"2015","unstructured":"Rosario V, Munoz-Louis R, Valdez T, et al. Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy. Clin Rheumatol. 2015;34(7):1285\u20137.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"273_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1590\/S0482-50042011000200005","volume":"51","author":"DC Titton","year":"2011","unstructured":"Titton DC, Silveira IG, Louzada-Junior P, et al. Brazilian biologic registry: biobadabrasil implementation process and preliminary results. Rev Bras Reumatol. 2011;51(2):152\u201360.","journal-title":"Rev Bras Reumatol"},{"key":"273_CR12","unstructured":"Minist\u00e9rio da Sa\u00fade do Brasil. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v\u00edrus Zika at\u00e9 a Semana Epidemiol\u00f3gica 52, 2016. 2017. Available at: https:\/\/antigo.saude.gov.br\/images\/pdf\/2017\/fevereiro\/05\/2017_002-Dengue%20SE52_corrigido.pdf"},{"issue":"Suppl 2","key":"273_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.rbr.2017.05.004","volume":"57","author":"CDL Marques","year":"2017","unstructured":"Marques CDL, Duarte ALBP, Ranzolin A, et al. Recommendations of the Brazilian society of rheumatology for diagnosis and treatment of Chikungunya fever part 1 - diagnosis and special situations. Rev Bras Reumatol Engl Ed. 2017;57(Suppl 2):421\u201337.","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"273_CR14","first-page":"1","volume":"140","author":"R Likert","year":"1932","unstructured":"Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;140:1\u201355.","journal-title":"Arch Psychol"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2334-8-99","volume":"8","author":"P G\u00e9rardin","year":"2008","unstructured":"G\u00e9rardin P, Guernier V, Perrau J, et al. Estimating chikungunya prevalence in La R\u00e9union Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis. 2008;8:99.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"273_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008549","volume":"14","author":"A Endale","year":"2020","unstructured":"Endale A, Michlmayr D, Abegaz WE, et al. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia. PLoS Negl Trop Dis. 2020;14(9): e0008549.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"273_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235322","volume":"15","author":"CC Chisenga","year":"2020","unstructured":"Chisenga CC, Bosomprah S, Musukuma K, et al. Sero-prevalence of arthropod-borne viral infections among Lukanga swamp residents in Zambia. PLoS ONE. 2020;15(7): e0235322.","journal-title":"PLoS ONE"},{"issue":"12","key":"273_CR18","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/s10067-020-05198-x","volume":"39","author":"M Bautista-Vargas","year":"2020","unstructured":"Bautista-Vargas M, Puerta-Sarmiento G, Ca\u00f1as CA. Characteristics of Chikungunya virus infection in patients with established rheumatoid arthritis. Clin Rheumatol. 2020;39(12):3639\u201342.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"273_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1086\/590003","volume":"47","author":"G Borgherini","year":"2008","unstructured":"Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008;47(4):469\u201375.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"273_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s13337-019-00534-5","volume":"30","author":"S Chelluboina","year":"2019","unstructured":"Chelluboina S, Robin S, Aswathyraj S, et al. Persistence of antibody response in chikungunya. Virusdisease. 2019;30(3):469\u201373.","journal-title":"Virusdisease"},{"key":"273_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nmni.2015.04.002","volume":"7","author":"A Pierro","year":"2015","unstructured":"Pierro A, Rossini G, Gaibani P, et al. Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy. New Microbes New Infect. 2015;7:23\u20135.","journal-title":"New Microbes New Infect"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-022-00273-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:11:08Z","timestamp":1668438668000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-022-00273-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s42358-022-00273-0","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each subject and all experimental procedures were approved by the Universidade Federal de Pernambuco ethics committee (certificate of ethical approval [CAAE] number 54275516.9.1001.5208).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. There is no relevant information to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}